MassDevice.com +5 | The top 5 medtech stories for April 18, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. St. Jude Medical touts 1st U.S. commercial implantations for Quadra Assura with MultiPoint pacing St. Jude Medical today touted the 1st U.S. commercial implantations for its Quadra Assura MP cardiac resynchronization therapy defibrillator, featuring its MultiPoint pacing technology. The MultiPoint tech is the 1st to hit the U.S. market that allows physicians to tailor pacing therapy by controlling multiple pulses to the left ventricle for each heartbeat. Each lead in the system can deliver 2 pulses per heartbeat, St. Jude said. Read more 4. Material in Medtronic’s cardiac leads makes the Space Technology Hall of Fame Medtronic said today that lead material used in its cardiac leads, NASA Langley Research Center-Soluble Imide, was inducted into the Space Technology Hall of Fame. The induction ceremony took place at the Space Foundation’s 32nd Space Symposium in Colorado Springs, Colo. Read more 3. Proteus Digital Health lands $50m Series H round Proteus Digital Health last week said that it raised a $50 million Series H equity round it plans to use to ex...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 5 Source Type: news

Related Links:

We present the case of a patient without previous diagnosis of relapsing polychondritis who was referred to our Institute with heart failure secondary to aortic regurgitation, initially attributed to endocarditis. PMID: 32459198 [PubMed - as supplied by publisher]
Source: Archivos de Cardiologia de Mexico - Category: Cardiology Authors: Tags: Arch Cardiol Mex Source Type: research
Conclusions: AD and CVD are frequently associated. Further studies are needed in order to understand the effect of CVD and its risk factors on AD in order to better comprehend the effects of subclinical and clinical CVD on the brain. Finally, we need to clarify the impact of the underlying hypothesized mechanisms of this association and to investigate gender issues. PMID: 32454996 [PubMed]
Source: Cardiology Research and Practice - Category: Cardiology Authors: Tags: Cardiol Res Pract Source Type: research
Recent evidence shows that THV prostheses anchoring occurs at the raphe-level, known as LIRA plane, in raphe-type bicuspid aortic valve (BAV) disease. The purpose of this study was to evaluate the application of a novel supra-annular sizing method, known as Level of Implantation at the RAphe (LIRA) method, to optimize transcatheter heart valve (THV) prosthesis sizing in raphe-type BAV disease.
Source: International Journal of Cardiology - Category: Cardiology Authors: Source Type: research
Conditions:   Coronary Artery Disease;   Aortic Valve Disease;   Mitral Valve Disease Intervention:   Procedure: Intensive early mobilization techniques Sponsors:   Dimitris Chatzitheodorou;   University of Macedonia, Thessaloniki, Greece Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Rheumatic heart disease (RHD) still affects more patients globally than degenerative valve disease. The vast majority of these patients live in low- to middle-income countries. Once symptomatic, they will need heart valve surgery. Unfortunately, prosthetic valves perform poorly in these patients given their young age, the high incidence of multi-valve disease, late diagnoses and often challenging socio-economic circumstances.Notwithstanding the fact that better valve designs would ideally be available, ill-informed decision making processes between bioprosthetic and mechanical valves are contributing to the poor results.
Source: International Journal of Cardiology - Category: Cardiology Authors: Source Type: research
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in patients with heart valve disease. Our aim was to summarize our experience and evaluate the efficacy and safety of the Cox maze III p...
Source: Journal of Cardiothoracic Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Research article Source Type: research
Publication date: June 2020Source: IJC Heart &Vasculature, Volume 28Author(s): Jo M. Zelis, Marcel van 't Veer, Saskia Houterman, Nico H.J. Pijls, Pim A.L. Tonino, On behalf of the Netherlands Heart Registration Transcatheter Heart valve Implantation Registration Committee
Source: IJC Heart and Vasculature - Category: Cardiology Source Type: research
ConclusionThese results demonstrate the establishment of a novel in vitro model for bacterial biofilm growth on porcine aortic roots mimicking IE. The model will allow to identify predilection sites of valves for bacterial adhesion and biofilm growth and it may serve as baseline for further research on IE therapy and prevention, e.g. the development of antimicrobial transcatheter approaches to IE.Graphic abstract
Source: Clinical Research in Cardiology - Category: Cardiology Source Type: research
Authors: Faroux L, Couture T, Guimaraes C, Junquera L, Del Val D, Muntané-Carol G, Wintzer-Wehekind J, Mohammadi S, Paradis JM, Delarochellière R, Kalavrouziotis D, Dumont E, Pasian S, Rodés-Cabau J Abstract OBJECTIVES: We sought to evaluate the position of balloon-expandable valves in relation to the coronary ostia using an angiographic- and computed tomography (CT)-based analysis, and to determine the impact of valve position on coronary angiography (CA)/percutaneous coronary intervention (PCI) feasibility and results. METHODS: A total of 533 patients who received a Sapien XT or Sapien 3 ...
Source: The Journal of Invasive Cardiology - Category: Cardiology Tags: J Invasive Cardiol Source Type: research
Transcatheter aortic valve implantation (TAVI) has revolutionized the management of patients with symptomatic severe aortic stenosis. Recently, the role of TAVI has expanded from the high surgical risk to low surgical risk patients.1-4 There are two commercially available transcatheter heart valve systems: self-expanding and balloon-expanding valves. In the pivotal trials comparing TAVI with surgical aortic valve replacement (SAVR), only one system was utilized in the individual trials.1,2,5-8 Studies providing a direct comparison between both devices are scarce.
Source: The American Journal of Cardiology - Category: Cardiology Authors: Source Type: research
More News: Cardiac Resynchronization Therapy | Cardiology | Health | Heart | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Medical Devices | Mergers and Aquisitions